Innate Pharma S.A. (EPA:IPH)
France · Delayed Price · Currency is EUR 1.340
-0.046 (-3.32%)
Nov 12, 2026, 9:35 AM CET
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €125.56 million as of November 11, 2026. It is the 22,576th most valuable company in the world and the 273rd biggest in France. Its market cap has decreased by 20.33% in one year.
Market Cap
125.56M
Enterprise Value
134.87M
Revenue
9.81M
Global Rank
Country Rank
#273 France
PE Ratio
n/a
ChartMarket Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 125.56M, an increase of 15,751.01%. That is a compound annual growth rate of 28.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 125.56M | -14.97% |
| Dec 31, 2025 | 147.67M | -7.67% |
| Dec 31, 2024 | 159.94M | -24.29% |
| Dec 29, 2023 | 211.24M | -19.93% |
| Dec 30, 2022 | 263.84M | -24.98% |
| Dec 31, 2021 | 351.67M | 28.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genfit | 550.34M |
| Valneva SE | 499.80M |
| Valerio Therapeutics Société anonyme | 247.23M |
| Transgene | 200.48M |
| Sensorion | 89.96M |
| Cellectis | 73.64M |
| ABIONYX Pharma | 65.79M |
| Adocia | 56.98M |